???pagination.result.count???
Antiarrhythmic drug carvedilol inhibits HERG potassium channels. , Karle CA., Cardiovasc Res. February 1, 2001; 49 (2): 361-70.
MinK subdomains that mediate modulation of and association with KvLQT1. , Tapper AR., J Gen Physiol. September 1, 2000; 116 (3): 379-90.
Dynamic control of deactivation gating by a soluble amino-terminal domain in HERG K(+) channels. , Wang J ., J Gen Physiol. June 1, 2000; 115 (6): 749-58.
Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline. , Jo SH., Br J Pharmacol. April 1, 2000; 129 (7): 1474-80.
Novel gain-of-function mechanism in K(+) channel-related long-QT syndrome: altered gating and selectivity in the HERG1 N629D mutant. , Lees-Miller JP., Circ Res. March 17, 2000; 86 (5): 507-13.
Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate. , Mitcheson JS., J Gen Physiol. March 1, 2000; 115 (3): 229-40.
Proton and zinc effects on HERG currents. , Anumonwo JM., Biophys J. July 1, 1999; 77 (1): 282-98.
Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels. , Kiehn J., Naunyn Schmiedebergs Arch Pharmacol. March 1, 1999; 359 (3): 212-9.
Regulation of deactivation by an amino terminal domain in human ether-à- go-go-related gene potassium channels. , Wang J ., J Gen Physiol. November 1, 1998; 112 (5): 637-47.
Modulation of human erg K+ channel gating by activation of a G protein-coupled receptor and protein kinase C. , Barros F., J Physiol. September 1, 1998; 511 ( Pt 2) 333-46.
Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action. , Busch AE., Br J Pharmacol. January 1, 1998; 123 (1): 23-30.
High affinity open channel block by dofetilide of HERG expressed in a human cell line. , Snyders DJ., Mol Pharmacol. June 1, 1996; 49 (6): 949-55.